{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,21]],"date-time":"2026-02-21T06:09:53Z","timestamp":1771654193493,"version":"3.50.1"},"reference-count":22,"publisher":"Oxford University Press (OUP)","issue":"7","license":[{"start":{"date-parts":[[2000,7,1]],"date-time":"2000-07-01T00:00:00Z","timestamp":962409600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/journals\/pages\/open_access\/funder_policies\/chorus\/standard_publication_model"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2000,7,1]]},"abstract":"<jats:title>Abstract<\/jats:title>\n               <jats:p>Pseudohypoparathyroidism (PHP) is a disorder characterized by hypocalcemia and secondary hyperparathyroidism caused by primarily renal resistance to the effects of parathyroid hormone (PTH). However, as an indication of normal PTH responsiveness in bone, some patients with PHP develop skeletal disease because of longstanding secondary hyperparathyroidism. A patient is described with hypocalcemia, hyperphosphatemia, marked secondary hyperparathyroidism, and an increased alkaline phosphatase level. Subsequent evaluation revealed a diagnosis of PHP type Ib. The patient had radiographic evidence of skeletal disease caused by secondary hyperparathyroidism. A urinary level of N-telopeptide cross-links of type I collagen (NTX) was elevated markedly. Bone mineral density (BMD) was in the normal range at all measured sites, with BMD at the spine being higher than at the femur and distal radius. Treatment was initiated with calcium and calcitriol. Seven months later, calcium and PTH levels had normalized. The level of urinary NTX fell by 83%. Spinal BMD improved by 15%, and BMD at the femoral neck improved by 11%. Radial BMD was unchanged. This case emphasizes the importance of evaluating patients with PHP for hyperparathyroid bone disease and shows that correction of secondary hyperparathyroidism in patients with PHP can result in a significant suppression of previously accelerated bone turnover and to substantial gains in BMD at sites containing a major percentage of cancellous bone. The case also implies that assessment of bone turnover with urinary NTX and measurement of BMD with dual-energy X-ray absorptiometry (DEXA) may be useful in following the response of the skeleton to therapy in these patients and suggests the need for more studies of both NTX and BMD in patients with PHP.<\/jats:p>","DOI":"10.1359\/jbmr.2000.15.7.1412","type":"journal-article","created":{"date-parts":[[2006,4,26]],"date-time":"2006-04-26T20:30:23Z","timestamp":1146083423000},"page":"1412-1416","source":"Crossref","is-referenced-by-count":19,"title":["Serial Changes in Bone Mineral Density and Bone Turnover After Correction of Secondary Hyperparathyroidism in a Patient with Pseudohypoparathyroidism Type Ib"],"prefix":"10.1093","volume":"15","author":[{"given":"Steven R.","family":"Tollin","sequence":"first","affiliation":[{"name":"Department of Medicine, Division of Endocrinology and Metabolism, Winthrop-University Hospital, Mineola, New York, U.S.A."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Steven","family":"Perlmutter","sequence":"additional","affiliation":[{"name":"Department of Radiology, The State University of New York at Stony Brook School of Medicine, Mineola, New York, U.S.A."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"John F.","family":"Aloia","sequence":"additional","affiliation":[{"name":"Department of Medicine, Division of Endocrinology and Metabolism, Winthrop-University Hospital, Mineola, New York, U.S.A."}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"286","published-online":{"date-parts":[[2009,12,2]]},"reference":[{"key":"2024020714092028500_bib1","first-page":"194","volume-title":"Primer on the Metabolic Bone Diseases","author":"Levine","year":"1993","edition":"2nd Ed."},{"key":"2024020714092028500_bib2","first-page":"1611","article-title":"Pseudohypoparathyroidism type Ib is not caused by mutations in the coding exons of the human parathyroid hormone (PTH)\/PTH-related peptide receptor gene","volume":"80","author":"Schipani","year":"1995","journal-title":"J Clin Endocrinol Metab"},{"key":"2024020714092028500_bib3","first-page":"1031","article-title":"Cloning and characterization of the promoter regions of the human parathyroid hormone (PTH)\/PTH-related peptide receptor gene: Analysis of deoxyribonucleic acid from normal subjects and patients with pseudohypoparathyroidism type lb","volume":"82","author":"Bettoun","year":"1997","journal-title":"J Clin Endocrinol Metab"},{"key":"2024020714092028500_bib4","doi-asserted-by":"crossref","first-page":"11798","DOI":"10.1073\/pnas.95.20.11798","article-title":"The gene responsible for pseudohypoparathyroidism type Ib is paternally imprinted and maps in four unrelated kindreds to chromosome 20q13.3","volume":"95","author":"Juppner","year":"1998","journal-title":"Proc Natl Acad Sci U S A"},{"key":"2024020714092028500_bib5","doi-asserted-by":"crossref","first-page":"772","DOI":"10.1016\/0002-9343(80)90270-3","article-title":"Skeletal responsiveness in pseudohypoparathyroidism: A spectrum of clinical disease","volume":"68","author":"Kidd","year":"1980","journal-title":"Am J Med"},{"key":"2024020714092028500_bib6","doi-asserted-by":"crossref","first-page":"638","DOI":"10.1210\/jcem-57-3-638","article-title":"Evidence for bone remodeling but lack of calcium mobilization response to parathyroid hormone in pseudohypoparathyroidism","volume":"57","author":"Breslau","year":"1983","journal-title":"J Clin Endocrinol Metab"},{"key":"2024020714092028500_bib7","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1002\/jbmr.5650080111","article-title":"Pseudohypoparathyroidism with osteitis fibrosa cystica: Direct demonstration of skeletal responsiveness to parathyroid hormone in cells cultured from bone","volume":"8","author":"Murray","year":"1993","journal-title":"J Bone Miner Res"},{"key":"2024020714092028500_bib8","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1007\/BF02208341","article-title":"Direct effect of calcitriol on the regulation of parathyroid secretion in a case of pseudohypoparathyroidism (a 24-month follow-up study)","volume":"14","author":"Giraud","year":"1995","journal-title":"Clin Rheumatol"},{"key":"2024020714092028500_bib9","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1002\/jbmr.5650110103","article-title":"Normal parathyroid hormone responsiveness of bone derived cells from a patient with pseudohypoparathyroidism","volume":"11","author":"Ish-Shalom","year":"1996","journal-title":"J Bone Miner Res"},{"key":"2024020714092028500_bib10","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1001\/archsurg.133.6.673","article-title":"Osteitis fibrosa cystica with renal parathyroid hormone resistance","volume":"133","author":"Eubanks","year":"1998","journal-title":"Arch Surg"},{"key":"2024020714092028500_bib11","first-page":"1016","article-title":"Pseudohypohyperparathyroidism-pseudohypoparathyroidism type Ib","volume":"6","author":"Farfel","year":"1999","journal-title":"J Bone Miner Res"},{"key":"2024020714092028500_bib12","first-page":"2012","volume-title":"Diagnosis of Bone and Joint disorders","author":"Resnick","year":"1995","edition":"3rd Ed."},{"key":"2024020714092028500_bib13","doi-asserted-by":"crossref","first-page":"1832","DOI":"10.1172\/JCI106149","article-title":"Pseudohypoparathyroidism: Defective excretion of 3\u20325\u2032-AMP in response to parathyroid hormone","volume":"48","author":"Chase","year":"1969","journal-title":"J Clin Invest"},{"key":"2024020714092028500_bib14","doi-asserted-by":"crossref","first-page":"771","DOI":"10.1172\/JCI108831","article-title":"Nephrogenous cyclic adenosine monophosphate as a parathyroid function test","volume":"60","author":"Broadus","year":"1977","journal-title":"J Clin Invest"},{"key":"2024020714092028500_bib15","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1002\/jbmr.5650040302","article-title":"Skeletal disease in primary hyperparathyroidism","volume":"4","author":"Silverberg","year":"1989","journal-title":"J Bone Miner Res"},{"key":"2024020714092028500_bib16","first-page":"729","article-title":"Increased bone mineral density after parathyroidectomy in primary hyperparathyroidism","volume":"80","author":"Silverberg","year":"1995","journal-title":"J Clin Endocrinol Metab"},{"key":"2024020714092028500_bib17","doi-asserted-by":"crossref","first-page":"641","DOI":"10.1002\/jbmr.5650100418","article-title":"Different effects of bisphosphonate and estrogen therapy on free and peptide-bound cross-links excretion","volume":"10","author":"Garnero","year":"1994","journal-title":"J Bone Miner Res"},{"key":"2024020714092028500_bib18","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1007\/BF00316285","article-title":"Specificiiy of urinary excretion of cross-linked N-telopeptides of type I collagen as a marker of bone turnover","volume":"54","author":"Rosen","year":"1994","journal-title":"Calcif Tissue Int"},{"key":"2024020714092028500_bib19","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1016\/S0002-9343(97)00137-X","article-title":"Biochemical markers in the assessment of bone disease","volume":"103","author":"Bilke","year":"1997","journal-title":"Am J Med"},{"key":"2024020714092028500_bib20","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/S0002-9343(96)00387-7","article-title":"Hormone replacement therapy in postmemopausal women: Urinary N-telopeptide of type I collagen monitors therapeutic effect and predicts response of bone mineral density","volume":"102","author":"Chesnut","year":"1997","journal-title":"Am J Med"},{"key":"2024020714092028500_bib21","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1002\/(SICI)1098-2388(199703\/04)13:2<125::AID-SSU8>3.0.CO;2-B","article-title":"Parathyroid function and bone metabolic markers in primary and secondary hyperparathyroidism","volume":"13","author":"Tanaka","year":"1997","journal-title":"Semin Surg Oncol"},{"key":"2024020714092028500_bib22","first-page":"3717","article-title":"Different responses of free and peptide-bound cross-links to vitamin D and calcium supplementation in elderly women with vitaimin D insufficiency","volume":"81","author":"Kamel","year":"1996","journal-title":"J Clin Endocrinol Metab"}],"container-title":["Journal of Bone and Mineral Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1359%2Fjbmr.2000.15.7.1412","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/academic.oup.com\/jbmr\/article-pdf\/15\/7\/1412\/56604271\/5650150721.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/jbmr\/article-pdf\/15\/7\/1412\/56604271\/5650150721.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,3,13]],"date-time":"2024-03-13T15:00:58Z","timestamp":1710342058000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/jbmr\/article\/15\/7\/1412-1416\/7515383"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2000,7,1]]},"references-count":22,"journal-issue":{"issue":"7","published-online":{"date-parts":[[2009,12,2]]},"published-print":{"date-parts":[[2000,7,1]]}},"URL":"https:\/\/doi.org\/10.1359\/jbmr.2000.15.7.1412","relation":{},"ISSN":["0884-0431","1523-4681"],"issn-type":[{"value":"0884-0431","type":"print"},{"value":"1523-4681","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2000,7,1]]},"published":{"date-parts":[[2000,7,1]]}}}